Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 7.


Johnson, Philip James ORCID: 0000-0003-1404-0209, Pinato, David J, Kalyuzhnyy, Anton and Toyoda, Hidenori
(2022) Breaking the Child-Pugh Dogma in Hepatocellular Carcinoma comment. JOURNAL OF CLINICAL ONCOLOGY, 40 (19). 2078-+.


Mishra, Gauri, Majeed, Ammar, Dev, Anouk, Eslick, Guy D, Pinato, David J, Izumoto, Hirofumi, Hiraoka, Atsushi, Huo, Teh-Ia, Liu, Po-Hong, Johnson, Philip J ORCID: 0000-0003-1404-0209
et al (show 1 more authors) (2022) Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysis. JOURNAL OF GASTROINTESTINAL CANCER, 54 (2). pp. 420-432.


Anpalakhan, Shobana, Huddar, Prerana, Behrouzi, Roya, Signori, Alessio, Cave, Judith, Comins, Charles, Cortellini, Alessio, Addeo, Alfredo, Escriu, Carles ORCID: 0000-0003-3638-3202, McKenzie, Hayley
et al (show 7 more authors) (2023) The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24 (2). 1746-.


Banna, Giuseppe L, Cantale, Ornella, Muthuramalingam, Sethupathi, Cave, Judith, Comins, Charles, Cortellini, Alessio, Addeo, Alfredo, Signori, Alessio, McKenzie, Hayley, Escriu, Carles ORCID: 0000-0003-3638-3202
et al (show 7 more authors) (2022) Efficacy outcomes and prognostic factors from real-world patients with advanced non-small-cell lung cancer treated with first-line chemoimmunotherapy: The Spinnaker retrospective study. INTERNATIONAL IMMUNOPHARMACOLOGY, 110. 108985-.


Sarker, Debashis, Plummer, Ruth, Meyer, Tim, Sodergren, Mikael H, Basu, Bristi, Chee, Cheng Ean, Huang, Kai-Wen, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Ting, Yuk, Evans, TR Jeff
et al (show 26 more authors) (2020) MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-a, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial. CLINICAL CANCER RESEARCH, 26 (15). pp. 3936-3946.


Han, Guohong, Berhane, Sarah, Toyoda, Hidenori, Bettinger, Dominik, Elshaarawy, Omar, Chan, Anthony WH, Kirstein, Martha, Mosconi, Cristina, Hucke, Florian, Palmer, Daniel ORCID: 0000-0002-7147-5703
et al (show 24 more authors) (2020) Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach. Hepatology (Baltimore, Md.), 72 (01). pp. 198-212.


Hashimoto, Ayumi, Sarker, Debashis, Reebye, Vikash, Jarvis, Sheba, Sodergren, Mikael H, Kossenkov, Andrew, Sanseviero, Emilio, Raulf, Nina, Vasara, Jenni, Andrikakou, Pinelopi
et al (show 21 more authors) (2021) Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer. CLINICAL CANCER RESEARCH, 27 (21). pp. 5961-5978.

This list was generated on Sun Apr 7 15:48:46 2024 BST.